Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME: Take the course for this article:
Volume 58, Number 7, April 09, 2002
Right arrow Correspondence:
Submit a response
Right arrow Correspondence:
View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Bie, R. M.A.
Right arrow Articles by Speelman, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Bie, R. M.A.
Right arrow Articles by Speelman, J. D.
Related Collections
Right arrow Parkinson's disease/Parkinsonism
Neurology 2002;58:1008-1012
© 2002 American Academy of Neurology


Views & Reviews

Morbidity and mortality following pallidotomy in Parkinson’s disease

A systematic review

R. M.A. de Bie, MD PhD, R. J. de Haan, PhD, P. R. Schuurman, MD, R. A.J. Esselink, MD, D. A. Bosch, MD PhD and J. D. Speelman, MD PhD

From the Departments of Neurology (Drs. de Bie, Esselink, and Speelman), Clinical Epidemiology and Biostatistics (Dr. de Haan), and Neurosurgery (Drs. Schuurman and Bosch), Academic Medical Center, University of Amsterdam, the Netherlands.

Address correspondence and reprint requests to Dr. J.D. Speelman, Department of Neurology (H2-222), Academic Medical Center, P.O. Box 22700, 1100 DE Amsterdam, the Netherlands; e-mail: j.d.speelman{at}amc.uva.nl

Objective: To study the frequency of morbidity and mortality associated with pallidotomy.

Method: The authors searched the MEDLINE electronic database for pallidotomy articles reported between January 1992 and December 2000. They selected studies by the following criteria: original clinical data, unequivocal description of morbidity and mortality, and unselected consecutive cases. The authors extracted the following data: number of patients, unilateral or bilateral procedures, age, localization technique, follow-up time, number of patients with adverse effects, number of patients with permanent adverse effects (>3 months), types of adverse effects, and mortality.

Results: For unilateral pallidotomy, 12 prospective studies included 334 patients. Of these patients, 30.2% (95% CI, 25.3 to 35.2) had adverse effects, and 13.8% (95% CI, 10.1 to 17.5) had permanent adverse effects. A symptomatic infarction or hemorrhage occurred in 3.9% (95% CI, 2.1 to 6.6). The mortality rate was 1.2% (95% CI, 0.3 to 3.0). In the series with microelectrode recording, the frequency of adverse effects was 14.4% (95% CI, 4.7 to 24.1) higher and the frequency of stroke was 4.9% (95% CI, 1.4 to 8.4) higher. The most frequent adverse effects were problems with speech (11.1%) and facial paresis (8.4%). For bilateral pallidotomy, five historical cohort studies including 20 patients were available for review. Fourteen patients had an adverse effect, and the most frequent adverse effects were impairments of speech and cognition.

Conclusions: The risk of permanent adverse effects associated with unilateral pallidotomy was 13.8%. A symptomatic infarction or hemorrhage occurred in 3.9% of patients, and the associated mortality rate was 1.2%.




This article has been cited by other articles:


Home page
JRSMHome page
E. A C Pereira and T. Z Aziz
Surgical insights into Parkinson's disease.
J R Soc Med, May 1, 2006; 99(5): 238 - 244.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
R R Goodman, B Kim, S McClelland III, P B Senatus, L M Winfield, S L Pullman, Q Yu, B Ford, and G M McKhann II
Operative techniques and morbidity with subthalamic nucleus deep brain stimulation in 100 consecutive patients with advanced Parkinson's disease
J. Neurol. Neurosurg. Psychiatry, January 1, 2006; 77(1): 12 - 17.
[Abstract] [Full Text] [PDF]


Home page
J Geriatr Psychiatry NeurolHome page
D. J. Burn and A. I. Troster
Neuropsychiatric Complications of Medical and Surgical Therapies for Parkinson's Disease
J Geriatr Psychiatry Neurol, September 1, 2004; 17(3): 172 - 180.
[Abstract] [PDF]


Home page
NeurologyHome page
V. Biousse, N. J. Newman, R. M. A. de Bie, and J. D. Speelman
Morbidity and mortality following pallidotomy in PD
Neurology, December 10, 2002; 59(11): 1822 - 1822.
[Full Text] [PDF]


Home page
JWatch NeurologyHome page
Assessing Morbidity and Mortality Associated with Pallidotomy
Journal Watch Neurology, July 25, 2002; 2002(725): 4 - 4.
[Full Text]

Correspondence:

Read all Correspondence

Morbidity and mortality following pallidotomy in Parkinson’s disease: A systematic review
Valerie Biousse, et al.
Neurology Online, 17 Jul 2002 [Full text]
Reply to Letter to the Editor
Johannes D. Speelman, et al.
Neurology Online, 17 Jul 2002 [Full text]



HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by AAN Enterprises, Inc.